Related Experiment Video
Updated: Dec 19, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
The Unexpected Risks of COVID-19 on Asthma Control in Children
Nicolas M Oreskovic1, T Bernard Kinane2, Emmanuel Aryee3
1Department of Pediatrics, Massachusetts General Hospital, Boston, Mass; Department of Internal Medicine, Massachusetts General Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.
Insights
The COVID-19 pandemic significantly altered asthma management for children. Environmental and healthcare changes impacted asthma control, highlighting areas for future research in pediatric asthma during pandemics.
Area of Science:
- Pediatric Pulmonology
- Epidemiology
- Public Health
Background:
- Limited understanding exists on how the COVID-19 pandemic affects the management of chronic conditions in children, specifically asthma.
- Asthma is a prevalent chronic condition in children, highly sensitive to environmental and behavioral shifts.
- The pandemic introduced significant changes in daily life, medical practices, and medication adherence, potentially impacting pediatric asthma control.
Purpose of the Study:
- To review the multifaceted impacts of the COVID-19 pandemic on the management and control of asthma in children and youth.
- To identify key environmental, social, and healthcare delivery factors influencing pediatric asthma during the pandemic.
- To highlight areas requiring further investigation regarding pediatric asthma outcomes in the context of the COVID-19 pandemic.
Main Methods:
- Literature review synthesizing current knowledge on pandemic-related changes affecting pediatric asthma.
- Analysis of how shifts in transportation, school environments, physical activity, and indoor time influence asthma control.
- Examination of alterations in healthcare access and delivery and their implications for managing childhood asthma.
Main Results:
- Changes in transportation, school attendance, physical activity levels, and indoor time have demonstrably affected asthma control in children.
- Altered healthcare delivery models and medication use patterns during the pandemic present new challenges for asthma management.
- The confluence of these factors creates a complex landscape for pediatric asthma care and outcomes.
Conclusions:
- The COVID-19 pandemic has substantially reshaped the management of asthma in children, necessitating a comprehensive understanding of these changes.
- Key areas influencing pediatric asthma control, including environmental exposures and healthcare access, require continued study.
- Further research is crucial to optimize asthma management strategies for children in the post-pandemic era and future public health crises.
Abstract:
Much is being learned about clinical outcomes for adult COVID-19 patients with underlying chronic conditions; however, there is less coverage on how the COVID-19 pandemic impacts the management of chronic medical conditions, such as asthma, in children and youth. Asthma is a common chronic medical condition in children that is uniquely susceptible to changes brought on by COVID-19. Sudden dramatic changes in the environment, medical practice, and medication use have altered the asthma management landscape with potential impacts on asthma outcomes. In this paper, we review how changes in transportation and travel patterns, school attendance, physical activity, and time spent indoors, along with changes in health care delivery since the start of the pandemic, all play a contributing role in asthma control in children. We review potentially important influences of asthma control in children during the COVID-19 pandemic worthy of further study.
More Related Videos
Related Concept Videos
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Nursing Management
First, in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...

